- Expression of xenobiotic and steroid hormone metabolizing enzymes in human breast carcinomas. Haas, S., Pierl, C., Harth, V., Pesch, B., Rabstein, S., Brüning, T., Ko, Y., Hamann, U., Justenhoven, C., Brauch, H., Fischer, H.P. Int. J. Cancer (2006)
- Direct assessment of promoter activity of human cytochrome p450 genes using optimized transfection in vitro and in vivo. Al-Dosari, M., Zhang, G., Knapp, J.E., Liu, D. Biosci. Rep. (2006)
- Hemodialysis acutely improves hepatic CYP3A4 metabolic activity. Nolin, T.D., Appiah, K., Kendrick, S.A., Le, P., McMonagle, E., Himmelfarb, J. J. Am. Soc. Nephrol. (2006)
- Cytochrome P450 enzymes: Central players in cardiovascular health and disease. Elbekai, R.H., El-Kadi, A.O. Pharmacol. Ther. (2006)
- Sulindac regulates the aryl hydrocarbon receptor-mediated expression of Phase 1 metabolic enzymes in vivo and in vitro. Ciolino, H.P., MacDonald, C.J., Memon, O.S., Bass, S.E., Yeh, G.C. Carcinogenesis (2006)
- Potential interactions of methylphenidate and atomoxetine with dextromethorphan. Ciccone, P.E., Ramabadran, K., Jessen, L.M. Journal of the American Pharmacists Association : JAPhA. (2006)
- Long lasting effects of prenatal exposure to deltamethrin on cerebral and hepatic cytochrome P450s and behavioral activity in rat offspring. Johri, A., Yadav, S., Singh, R.L., Dhawan, A., Ali, M., Parmar, D. Eur. J. Pharmacol. (2006)
- Metabolic basis of ethanol-induced cytotoxicity in recombinant HepG2 cells: Role of nonoxidative metabolism. Wu, H., Cai, P., Clemens, D.L., Jerrells, T.R., Ansari, G.A., Kaphalia, B.S. Toxicol. Appl. Pharmacol. (2006)
- Tissue specificity of induction of hamster monooxygenase activity by ethanol. Ueng, T.H., Ju, J.M., Tsai, J.N. Proc. Natl. Sci. Counc. Repub. China B (1989)
- Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Gough, A.C., Miles, J.S., Spurr, N.K., Moss, J.E., Gaedigk, A., Eichelbaum, M., Wolf, C.R. Nature (1990)
- An erythromycin derivative produced by targeted gene disruption in Saccharopolyspora erythraea. Weber, J.M., Leung, J.O., Swanson, S.J., Idler, K.B., McAlpine, J.B. Science (1991)
- The regulation of cytochrome P-450 gene expression. Whitlock, J.P. Annu. Rev. Pharmacol. Toxicol. (1986)
- Toxicology of thiono-sulfur compounds. Neal, R.A., Halpert, J. Annu. Rev. Pharmacol. Toxicol. (1982)
- Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. Nakagawa, K., Holla, V.R., Wei, Y., Wang, W.H., Gatica, A., Wei, S., Mei, S., Miller, C.M., Cha, D.R., Price, E., Zent, R., Pozzi, A., Breyer, M.D., Guan, Y., Falck, J.R., Waterman, M.R., Capdevila, J.H. J. Clin. Invest. (2006)
- Renal pathophysiology after systemic administration of recombinant adenovirus: changes in renal cytochromes P450 based on vector dose. Le, H.T., Boquet, M.P., Clark, E.A., Callahan, S.M., Croyle, M.A. Hum. Gene Ther. (2006)
- Population Pharmacokinetics of the BEACOPP Polychemotherapy Regimen in Hodgkin's Lymphoma and its Effect on Myelotoxicity. Wilde, S., Jetter, A., Rietbrock, S., Kasel, D., Engert, A., Josting, A., Klimm, B., Hempel, G., Reif, S., Jaehde, U., Merkel, U., Busse, D., Schwab, M., Diehl, V., Fuhr, U. Clinical pharmacokinetics (2007)
- Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury. Seubert, J.M., Zeldin, D.C., Nithipatikom, K., Gross, G.J. Prostaglandins Other Lipid Mediat. (2007)
- The Potential for Clinically Significant Drug-Drug Interactions Involving the CYP 2D6 System: Effects with Fluoxetine and Paroxetine versus Sertraline. Preskorn, S.H., Shah, R., Neff, M., Golbeck, A.L., Choi, J. Journal of psychiatric practice (2007)
- Hydroxylation of Oleanolic Acid to Queretaroic Acid by Cytochrome P450 from Nonomuraea recticatena. Fujii, Y., Hirosue, S., Fujii, T., Matsumoto, N., Agematu, H., Arisawa, A. Biosci. Biotechnol. Biochem. (2006)
- Cloning and expression of koala (Phascolarctos cinereus) liver cytochrome P450 CYP4A15. Ngo, S.N., McKinnon, R.A., Stupans, I. Gene (2006)
- An evaluation of the cytochrome p450 inhibition potential of lisdexamfetamine in human liver microsomes. Krishnan, S., Moncrief, S. Drug Metab. Dispos. (2007)
- Induction of Cytochrome P450: Assessment in an Immortalized Human Hepatocyte Cell Line (Fa2N4) Using a Novel Higher Throughput Cocktail Assay. Youdim, K.A., Tyman, C.A., Jones, B.C., Hyland, R. Drug Metab. Dispos. (2007)
- Genetic variation of human cytochrome p450 reductase as a potential biomarker for mitomycin C-induced cytotoxicity. Wang, S.L., Han, J.F., He, X.Y., Wang, X.R., Hong, J.Y. Drug Metab. Dispos. (2007)
- Significant transcriptional down-regulation of the human MDR1 gene by beta-naphthoflavone: A proposed hypothesis linking potent CYP gene induction to MDR1 inhibition. Nwankwo, J.O. Med. Hypotheses (2007)
- In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug. Brandon, E.F., Sparidans, R.W., van Ooijen, R.D., Meijerman, I., Lazaro, L.L., Manzanares, I., Beijnen, J.H., Schellens, J.H. Investigational new drugs (2007)
- Utility of long-term cultured human hepatocytes as an in vitro model for cytochrome p450 induction. Meneses-Lorente, G., Pattison, C., Guyomard, C., Chesné, C., Heavens, R., Watt, A.P., Sohal, B. Drug Metab. Dispos. (2007)
- Skin Retinoid Concentrations Are Modulated by CYP26AI Expression Restricted to Basal Keratinocytes in Normal Human Skin and Differentiated 3D Skin Models. Heise, R., Mey, J., Neis, M.M., Marquardt, Y., Joussen, S., Ott, H., Wiederholt, T., Kurschat, P., Megahed, M., Bickers, D.R., Merk, H.F., Baron, J.M. J. Invest. Dermatol. (2006)
- Effects of repeated green tea catechin administration on human cytochrome p450 activity. Chow, H.H., Hakim, I.A., Vining, D.R., Crowell, J.A., Cordova, C.A., Chew, W.M., Xu, M.J., Hsu, C.H., Ranger-Moore, J., Alberts, D.S. Cancer Epidemiol. Biomarkers Prev. (2006)
- Cytochrome p450 and glutathione s-transferase mRNA expression in human fetal liver hematopoietic stem cells. Shao, J., Stapleton, P.L., Lin, Y.S., Gallagher, E.P. Drug Metab. Dispos. (2007)
- Identification of human cytochrome p450 isozymes involved in diphenhydramine N-demethylation. Akutsu, T., Kobayashi, K., Sakurada, K., Ikegaya, H., Furihata, T., Chiba, K. Drug Metab. Dispos. (2007)
- Oxygenation of omega-3 fatty acids by human cytochrome P450 4F3B: Effect on 20-hydroxyeicosatetraenoic acid production. Harmon, S.D., Fang, X., Kaduce, T.L., Hu, S., Raj Gopal, V., Falck, J.R., Spector, A.A. Prostaglandins Leukot. Essent. Fatty Acids (2006)
- High levels of expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Cresteil, T., Jaiswal, A.K. Biochem. Pharmacol. (1991)
- The roles of NADH in the support of steroid aromatization by human placental microsomes. Sheean, L.A., Meigs, R.A. Steroids (1983)
- Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Jäättelä, M., Ilvesmäki, V., Voutilainen, R., Stenman, U.H., Saksela, E. Endocrinology (1991)
- Interaction of H2-receptor antagonists and benzodiazepine sedation. A double-blind placebo-controlled investigation of the effects of cimetidine and ranitidine on recovery after intravenous midazolam. Sanders, L.D., Whitehead, C., Gildersleve, C.D., Rosen, M., Robinson, J.O. Anaesthesia. (1993)
- Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients. Watkins, P.B., Murray, S.A., Winkelman, L.G., Heuman, D.M., Wrighton, S.A., Guzelian, P.S. J. Clin. Invest. (1989)
- Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Pascoe, L., Curnow, K.M., Slutsker, L., Connell, J.M., Speiser, P.W., New, M.I., White, P.C. Proc. Natl. Acad. Sci. U.S.A. (1992)
- Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. Shimada, T., Misono, K.S., Guengerich, F.P. J. Biol. Chem. (1986)
- An evaluation of cytochrome P450 isoform activities in the female dark agouti (DA) rat: relevance to its use as a model of the CYP2D6 poor metaboliser phenotype. Barham, H.M., Lennard, M.S., Tucker, G.T. Biochem. Pharmacol. (1994)
- Linkage relationships of the apolipoprotein C1 gene and a cytochrome P450 gene (CYP2A) to myotonic dystrophy. Walsh, K.V., Harley, H.G., Brook, J.D., Rundle, S.A., Sarfarazi, M., Harper, P.S., Shaw, D.J. Hum. Genet. (1990)
- Structural modelling of the human drug-metabolizing cytochromes p450. Lewis, D.F., Ito, Y., Goldfarb, P.S. Current medicinal chemistry. (2006)
- Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems. Stiborov??, M., Borek-Dohalsk??, L., Aimov??, D., Kotrbov??, V., Kukackov??, K., Janouchov??, K., Rupertov??, M., Ryslav??, H., Hudecek, J., Frei, E. Gen. Physiol. Biophys. (2006)
- Cytochrome P450-dependent arachidonic acid metabolism in human kidney. Schwartzman, M.L., Martasek, P., Rios, A.R., Levere, R.D., Solangi, K., Goodman, A.I., Abraham, N.G. Kidney Int. (1990)